Holly Maria Adams, FNP-BC, MSN

Holly Adams practices at Poplar Bluff HMA Physician Management in Poplar Bluff, Missouri.

Holly Adams' NPI, 1841899614, was assigned on October 22, 2020. Holly Adams holds Missouri license 2020035544.

Holly Adams' primary practice is Poplar Bluff HMA Physician Management, at 3098 Oak Grove Rd, Poplar Bluff, MO 63901 in Butler County. The practice phone is (573) 776-2835.

Holly Adams' primary practice is Poplar Bluff HMA Physician Management in Poplar Bluff, Missouri. Holly Adams is also affiliated with Poplar Bluff Regional Medical Center. The medical group on file is Missouri Highlands Health Care. Dmand AI also links Holly Adams to 1 more hospital, 1 community health center, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Holly Adams practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Holly Adams' primary specialty in the NPI Registry, under taxonomy code 363L00000X. Holly Adams is licensed in Missouri.

CMS counts 312 Medicare patients who saw Holly Adams in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Holly Adams' median patient age at 68, with 66% women.

In 2024, Holly Adams wrote 2,164 Medicare Part D claims for 456 patients. 87% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Holly Adams for performance year 2024, reported through an alternative payment model (APM). Holly Adams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Holly Adams as offering telehealth.

CMS Open Payments shows 2 general payments to Holly Adams from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $124.